← Full evidence page

For the cleanest result, disable browser headers and footers.

Dediabetes Evidence Brief

Beta-Cell Function

Evidence related to Beta-Cell Function.

Brief accessed
—

Full evidence pagehttps://www.dediabetes.com/evidence/beta-cell-function

Executive Summary

Beta-Cell Function evidence appears to center on Lifestyle intervention for prediabetes.

Among 27 indexed studies and 31 interventions, the strongest signals are summarized from the available evidence. Lifestyle intervention for prediabetes appears to be one of the clearer current evidence signals.

  • No strong consistent positive evidence pattern was detected.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Evidence Snapshot

Studies analyzed
27
Evidence relationships
31
Interventions
31
Outcomes
2
Strong evidence signals
0
Mixed evidence areas
0

Key Findings

  1. 01

    Across 2 studies, Lifestyle intervention for prediabetes shows a consistent neutral signal for Homeostatic Model Assessment of Beta-cell function (HOMA-β).

  2. 02

    Across 1 study, Acarbose shows a strong positive signal for Beta-cell function.

  3. 03

    Across 1 study, Digital-based lifestyle intervention shows a neutral signal for Beta-cell function.

  4. 04

    Across 1 study, Exenatide shows a neutral signal for Beta-cell function.

Question Highlights

Which interventions have evidence across beta-cell function measures?

Lifestyle intervention for prediabetes, Acarbose, and Aerobic exercise are among the most studied approaches for beta-cell function measures.

Lifestyle intervention for prediabetes, Acarbose, and Joint Asia Diabetes Evaluation (JADE)-PRISM are among the best-supported options in the available evidence across 27 studies.

Read the full answer

Does Lifestyle intervention for prediabetes improve homeostatic model assessment of beta-cell function (homa-β)?

Current evidence does not show a clear benefit of Lifestyle intervention for prediabetes for homeostatic model assessment of beta-cell function (homa-β).

Moderate evidence is based on 2 supporting studies.

Only a small number of supporting studies are available.

Read the full answer

Lifestyle intervention for prediabetes vs Acarbose for beta-cell function measures?

Lifestyle intervention for prediabetes and Acarbose have available evidence for beta-cell function measures, but the comparison requires review of the underlying studies.

Evidence is available for both Acarbose and Lifestyle intervention for prediabetes; the underlying studies are needed for a direct comparison.

Read the full answer

Evidence Categories

The evidence is organized by how consistently it supports a conclusion and how much research is available.

Well-Supported Interventions

The strongest and most consistent evidence for improving this outcome.

No strong consistent positive evidence pattern was detected.

Interpretation

The current evidence does not yet show a clear consistent-benefit pattern.

Findings Requiring Careful Interpretation

Results that vary across studies or depend on population, study design, duration, or comparator.

Some evidence is positive, but results are not consistent across all studies.

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Digital-based lifestyle intervention is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Leading examples

Digital-based lifestyle intervention · Vegan meal (V-meal)

Evidence basis: 2 evidence pairs - 2 studies

Emerging Areas of Research

Early positive signals that require additional high-quality research.

Early findings are encouraging, but stronger trials are needed.

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Acarbose may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Leading examples

Acarbose · Dapagliflozin 10 mg/day · F-Biotic Arishina

Evidence basis: 5 evidence pairs - 5 studies

About this Evidence Brief

This brief summarizes research currently indexed by Dediabetes Evidence Intelligence. It is not a clinical guideline or personalized medical recommendation. Evidence classifications may change as additional studies are indexed.

Suggested citation

—